Healy Jamesinsider trades
In SEC Form 4 filings, Healy James is listed as Director of Rapport Therapeutics, Inc. (RAPP). In the last 90 days, Healy James bought $20.36M of Rapport Therapeutics, Inc. (RAPP) on the open market and sold none. The largest purchase was $20.00M of Rapport Therapeutics, Inc. (RAPP) on Oct 28. Took part in a cluster buy; the latest at Rapport Therapeutics, Inc. (RAPP), where 7 insiders bought within 8 days, ending Oct 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | Director | 4 | Oct 30 |
Cluster buys
- RAPP: 7 insiders bought $22.02M between Oct 21 – Oct 28.
Form 4 historysince 2026-10-30
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | Oct 28 | Oct 30 | P | 952,380 | $21.00 | Purchase +$19,999,980 | 2,815,707 | No | Form 4 |
| RAPPRapport Therapeutics, Inc. | Oct 28 | Oct 30 | P | 6,395 | $21.00 | Purchase +$134,295 | 17,990 | No | Form 4 |
| RAPPRapport Therapeutics, Inc. | Oct 28 | Oct 30 | P | 3,772 | $21.00 | Purchase +$79,212 | 14,924 | No | Form 4 |
| RAPPRapport Therapeutics, Inc. | Oct 28 | Oct 30 | P | 6,933 | $21.00 | Purchase +$145,593 | 25,267 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.